263 related articles for article (PubMed ID: 31412151)
1. Intravitreal dexamethasone implants for non-infectious uveitis.
McCartney M; McCluskey P; Zagora S
Clin Exp Ophthalmol; 2019 Dec; 47(9):1156-1163. PubMed ID: 31412151
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone Inserts in Noninfectious Uveitis: A Single-Center Experience.
Pohlmann D; Vom Brocke GA; Winterhalter S; Steurer T; Thees S; Pleyer U
Ophthalmology; 2018 Jul; 125(7):1088-1099. PubMed ID: 29459041
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis.
Hasanreisoğlu M; Özdemir HB; Özkan K; Yüksel M; Aktaş Z; Atalay HT; Özdek Ş; Gürelik G
Turk J Ophthalmol; 2019 Oct; 49(5):250-257. PubMed ID: 31650791
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal Dexamethasone Implant for the Treatment of Macular Edema in Chronic Non-infectious Uveitis.
Tsang AC; Virgili G; Abtahi M; Gottlieb CC
Ocul Immunol Inflamm; 2017 Oct; 25(5):685-692. PubMed ID: 27191685
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of a Dexamethasone Implant for the Treatment of Refractory Cystoid Macular Oedema in Non-Infectious Uveitis].
Breitbach M; Rack D; Dietzel M; Heinz C; Heiligenhaus A
Klin Monbl Augenheilkd; 2016 May; 233(5):601-5. PubMed ID: 27187880
[TBL] [Abstract][Full Text] [Related]
6. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.
Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A
Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
[TBL] [Abstract][Full Text] [Related]
8. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
9. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal dexamethasone implant for noninfectious uveitis in Chinese patients.
Zeng S; Yang L; Bai F; Liu T; Liu X
Int Ophthalmol; 2022 Jul; 42(7):2063-2069. PubMed ID: 34984627
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of dexamethasone intravitreal implant for refractory macular edema in children.
Lei S; Lam WC
Can J Ophthalmol; 2015 Jun; 50(3):236-41. PubMed ID: 26040225
[TBL] [Abstract][Full Text] [Related]
12. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
Khurana RN; Porco TC
Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
[TBL] [Abstract][Full Text] [Related]
13. Ozurdex for refractory macular edema secondary to diabetes, vein occlusion, uveitis and pseudophakia.
Teja S; Sawatzky L; Wiens T; Maberley D; Ma P
Can J Ophthalmol; 2019 Oct; 54(5):540-547. PubMed ID: 31564342
[TBL] [Abstract][Full Text] [Related]
14. Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Singer MA; Capone A; Dugel PU; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Apr; 15():33. PubMed ID: 25885285
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.
Nobre-Cardoso J; Champion E; Darugar A; Fel A; Lehoang P; Bodaghi B
Ocul Immunol Inflamm; 2017 Aug; 25(4):447-454. PubMed ID: 27003221
[TBL] [Abstract][Full Text] [Related]
16. Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.
Fabiani C; Vitale A; Emmi G; Lopalco G; Vannozzi L; Bacherini D; Guerriero S; Favale RA; Fusco F; Franceschini R; Frediani B; Iannone F; Galeazzi M; Tosi GM; Cantarini L
J Ocul Pharmacol Ther; 2017 Sep; 33(7):549-555. PubMed ID: 28557602
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Intravitreal Dexamethasone Implant for Refractory Uveitic Macular Edema in Adults and Children.
Ratra D; Barh A; Banerjee M; Ratra V; Biswas J
Ocul Immunol Inflamm; 2018; 26(7):1034-1040. PubMed ID: 29394119
[TBL] [Abstract][Full Text] [Related]
18. PROSPECTIVE EVALUATION OF A SUSTAINED-RELEASE DEXAMETHASONE INTRAVITREAL IMPLANT FOR CYSTOID MACULAR EDEMA IN QUIESCENT UVEITIS.
Khurana RN; Bansal AS; Chang LK; Palmer JD; Wu C; Wieland MR
Retina; 2017 Sep; 37(9):1692-1699. PubMed ID: 27893624
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series.
Larochelle MB; Smith J; Dacey MS
Am J Ophthalmol; 2016 Jun; 166():149-153. PubMed ID: 27066725
[TBL] [Abstract][Full Text] [Related]
20. Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex® in patients with uveitic cystoid macular edema.
Bansal P; Agarwal A; Gupta V; Singh R; Gupta A
Indian J Ophthalmol; 2015 May; 63(5):416-22. PubMed ID: 26139803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
